LP-65 is a dual-function inhibitor that targets both MEK (IC50=83.2 nM) and mTOR (IC50=40.5 nM). It disrupts the MEK and mTOR signaling pathways, effectively inhibiting the proliferation and migration of tumor cells. LP-65 shows potential for use in cancer research.
Target:
mTOR|||MEK
* VAT and and shipping costs not included. Errors and price changes excepted
